Peer-reviewed veterinary case report
Cat in Brazil with facial sores and breathing trouble cured
By Liliane Lima da Silva Lomônaco et al.·Published in Medical Mycology Case Reports·2020·Veterinarian Autonomous, Fortaleza/CE, Brazil, NL·View original on DOAJ →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Disseminated histoplasmosis in a cat rescued in Fortaleza, Brazil, and successfully treated with itraconazole – First case report identified molecularly
- Species:
- cat
Plain-English summary
A female cat with no known age was brought in with bloody sores on her swollen face and trouble breathing. Tests revealed she had a fungal infection caused by Histoplasma, which is a type of fungus that can affect cats. The vet treated her with an antifungal medication called itraconazole for four months. After the treatment, the cat recovered well and showed significant improvement in her symptoms.
People also search for: cat respiratory problems · cat skin sores treatment · histoplasmosis in cats · itraconazole for cats · why is my cat breathing hard
Abstract
An unneutered female cat of unknown age presented bloody lesions on the edematous face, and respiratory signs. Cytology and culture from the skin sample collected with fine-needle aspiration showed yeasts inside activated macrophages, and fungal growth characteristic of Histoplasma spp., which was molecularly confirmed that was Histoplasma capsulatum var. capsulatum. The cat was successfully treated with oral itraconazole (10 mg/kg/daily) for 120 days. This is the first case report of feline histoplasmosis confirmed molecularly in Brazil.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on DOAJ: https://doi.org/10.1016/j.mmcr.2020.09.005